Amlodipine-induced gingival hyperplasia: A report of two cases

Abstract

Drugs associated with gingival overgrowth fall into three broad categories – anticonvulsants, immune suppressants and calcium channel blockers. Amlodipine is a third-generation dihydropyridine. The prevalence of amlodipine-induced gingival hyperplasia is 4.2%. We report two patients with the amlodipine-induced gingival hyperplasia.

Keywords

• amlodipine
• anticonvulsants
• calcium channel blockers
• drug-induced gingival overgrowth
• gingival hyperplasia
• immune suppressants